Statistics on Biotechnology Use Results by fields of operation Company sector. Biotechnology results by main variables and no. of employees. Unidades: specified in variables Fewer than 250 employees 250 or more employees Total 2019 No. of companies carrying out R&D in Biotechnology 1.095 103 1.198 %Companies according to biotechnology used: Genetic code 32,4 42,9 33,3 %Companies according to biotechnology used: Functional units 38,5 54,6 39,8 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 23,2 35,1 24,2 %Companies according to biotechnology used: Bioprocesses 48 66,9 49,6 %Companies according to biotechnology used: Sub-cellular organisms 6 13,9 6,7 %Companies according to biotechnology used: Bio-computing 23,9 23,9 23,9 %Companies according to biotechnology used: Nanobiotechnology 11,1 11,8 11,2 %Companies according to biotechnology used: Other 15,3 6,9 14,6 Companies in which biotechnology activities are: Main and/or exclusive 616 28 644 Companies in which biotechnology activities are: A secondary line of business 155 16 171 Companies in which biotechnology activities are: A tool necessary for production 324 59 383 %Company by field(s) of ultimate application of biotechnology use: Human Health 47,5 44,8 47,3 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 20,3 9,9 19,4 %Company by field(s) of ultimate application of biotechnology use: Food products 32,1 37,2 32,5 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 24,4 20,9 24,1 %Company by field(s) of ultimate application of biotechnology use: Environment 14,7 17,6 14,9 %Company by field(s) of ultimate application of biotechnology use: Industry 13,1 9,9 12,8 Personnel in R&D in biotechnology (no. of persons) 9.761 3.853 13.615 Personnel in R&D in biotechnology (no. of persons): Researchers 5.539 1.898 7.436 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 4.223 1.956 6.178 Personnel in R&D in biotechnology (no. of persons): women 5.266 2.373 7.639 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 2.968 1.127 4.095 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 2.298 1.246 3.544 Personnel in R&D in biotechnology (FTE) 6.635,9 2.729,4 9.365,2 Personnel in R&D in biotechnology (FTE): Researchers 4.020,1 1.390,4 5.410,6 Personnel in R&D in biotechnology (FTE): Technicians and assistants 2.615,7 1.338,9 3.954,6 Personnel in R&D in biotechnology (FTE): women 3.632,6 1.753,2 5.385,8 Personnel in R&D in biotechnology (FTE): (women) Researchers 2.192,4 840,5 3.032,9 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 1.440,2 912,6 2.352,9 Internal expenditure on R&D (thousands of euros) 677.192 263.038 940.230 1) By nature of the expense: Current expenses 626.080 245.733 871.813 1.1) Remuneration to researchers 200.684 84.252 284.936 1.2) Remuneration to technicians and assistants 87.267 60.987 148.254 1.3) Other current expenses 338.128 100.494 438.623 2) By nature of the expense: Capital expenses 51.113 17.304 68.417 2.1) Land and buildings 8.402 3.361 11.763 2.2) Equipment and instruments 26.572 13.069 39.641 2.3) Acquisition of specific R&D software 2.155 676 2.831 2.4) Otros productos de propiedad intelectual específicos para I+D 13.985 199 14.183 1.1) By origin of the funds: Own funds 427.439 149.847 577.287 1.2) By origin of the funds: From companies 104.912 37.760 142.672 1.3) By origin of the funds: Public Administration funds 81.268 21.363 102.630 1.4) By origin of the funds: From Universities 425 32 457 1.5) By origin of the funds: From non profit private institutions 2.098 7.533 9.631 1.6) By origin of the funds: Foreign funds 61.050 46.503 107.553 Purchase of R&D services in biotechnology (thousands of euros) 64.508 50.330 114.839 Purchase of R&D services in biotechnology (thousands of euros): In Spain 27.696 41.562 69.258 Purchase of R&D services in biotechnology (thousands of euros): Abroad 36.813 8.768 45.581 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 43,3 26,1 41,8 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12,1 11,1 12 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 13,3 11 13,1 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 10,6 11,2 10,7 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 15,8 8,1 15,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 16,5 7 15,7 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16,1 13,5 15,9 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 38 31 37 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 51,7 40,1 50,7 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19,7 11,9 19 % Companies that have requested biotechnology patents in Biotechnology 18,3 18,6 18,3 Number of patents requested 554 89 643 % Companies with income of an international origin related to biotechnological activities 25,2 16,1 24,4 % Turnover representing income of an international origin related to biotechnological activities 7,1 0,9 1,6 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 39,7 70,9 55,7 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 60,3 29,1 44,3 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 90,9 50,7 70,3 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 4,9 41,9 23,9 % Income of an international origin related with activities according to the classification: Operating source abroad 3,2 7,2 5,3 % Income of an international origin related with activities according to the classification: Other 1,1 0,1 0,6 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute